Author:
Miyatake Takashi,Ueda Yutaka,Morimoto Akiko,Enomoto Takayuki,Nishida Sumiyuki,Shirakata Toshiaki,Oka Yoshihiro,Tsuboi Akihiro,Oji Yusuke,Hosen Naoki,Nakatsuka Shin-ichi,Morita Satoshi,Sakamoto Junichi,Sugiyama Haruo,Kimura Tadashi
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference17 articles.
1. Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, Hecht TT, Mellman I, Prindiville SA, Viner JL, Weiner LM, Matrisian LM (2009) The prioritization of cancer antigens: a National Cancer Institute pilot project for the acceleration of translational research. Clin Cancer Res 15:5323–5337
2. Chiyoda T, Tsuda H, Nomura H, Kataoka F, Tominaga E, Suzuki A, Susumu N, Aoki D (2010) Effects of third-line chemotherapy for women with recurrent ovarian cancer who received platinum/taxane regimens as first-line chemotherapy. Eur J Gynaecol Oncol 31:364–368
3. DiSaia PJ, Creasman WT (2002) Clinical gynecologic oncology, 6th edn. St Louis, Mosby
4. Dizon DS, Dupont J, Anderson S, Sabbatini P, Hummer A, Aghajanian C, Spriggs D (2003) Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel. The memorial sloan-kettering cancer center experience. Gynecol Oncol 91:584–590
5. Dohi S, Ohno S, Ohno Y, Takakura M, Kyo S, Soma G, Sugiyama H, Inoue M (2011) WT1 peptide vaccine stabilized intractable ovarian cancer patient for one year: a case report. Anticancer Res 31:2441–2445
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献